Healthcare provider profile · identity verified

Peter Vaccaro

Internal Medicine · BRADFORD, PA · NPI 1942262563

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	453	131
Levothyroxine Sodium	Levothyroxine Sodium	452	101
Omeprazole	Omeprazole	370	105
Amlodipine Besylate	Amlodipine Besylate	351	107
Losartan Potassium	Losartan Potassium	336	96
Rosuvastatin Calcium	Rosuvastatin Calcium	335	111
Lisinopril	Lisinopril	326	99
Simvastatin	Simvastatin	240	67
Metformin Hcl	Metformin Hcl	230	78
Potassium Chloride	Potassium Chloride	227	52
Eliquis	Apixaban	225	38
Metoprolol Tartrate	Metoprolol Tartrate	208	52
Metoprolol Succinate	Metoprolol Succinate	205	61
Pantoprazole Sodium	Pantoprazole Sodium	203	69
Meloxicam	Meloxicam	202	58
Sertraline Hcl	Sertraline Hcl	198	44
Carvedilol	Carvedilol	155	45
Atenolol	Atenolol	149	53
Tamsulosin Hcl	Tamsulosin Hcl	145	37
Prednisone	Prednisone	143	99
Clopidogrel	Clopidogrel Bisulfate	141	39
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	140	62
Gabapentin	Gabapentin	139	39
Albuterol Sulfate Hfa	Albuterol Sulfate	120	41
Donepezil Hcl	Donepezil Hcl	115	17
Hydrochlorothiazide	Hydrochlorothiazide	113	31
Trazodone Hcl	Trazodone Hcl	107	22
Famotidine	Famotidine	105	22
Memantine Hcl	Memantine Hcl	89	16
Alprazolam	Alprazolam	87	42
Montelukast Sodium	Montelukast Sodium	85	21
Torsemide	Torsemide	81	25
Furosemide	Furosemide	78	20
Azithromycin	Azithromycin	76	67
Ozempic	Semaglutide	73	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	67	17
Duloxetine Hcl	Duloxetine Hcl	67	19
Ezetimibe	Ezetimibe	66	25
Xarelto	Rivaroxaban	65	25
Warfarin Sodium	Warfarin Sodium	64	19
Fluticasone Propionate	Fluticasone Propionate	63	21
Bumetanide	Bumetanide	62	12
Alendronate Sodium	Alendronate Sodium	61	21
Allopurinol	Allopurinol	60	19
Mirtazapine	Mirtazapine	60	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	57	39
Spironolactone	Spironolactone	55	18
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	54	12
Tramadol Hcl	Tramadol Hcl	53	31
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	51	13
Nifedipine Er	Nifedipine	50	13
Paroxetine Hcl	Paroxetine Hcl	48	suppressed
Glipizide	Glipizide	47	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	15
Oxybutynin Chloride	Oxybutynin Chloride	45	suppressed
Lorazepam	Lorazepam	44	13
Pravastatin Sodium	Pravastatin Sodium	44	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	43	suppressed
Glimepiride	Glimepiride	43	20
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	42	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	31
Ventolin Hfa	Albuterol Sulfate	35	13
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Buspirone Hcl	Buspirone Hcl	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	13
Celecoxib	Celecoxib	31	12
Divalproex Sodium	Divalproex Sodium	31	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	11
Carbidopa-Levodopa-Entacapone	Carbidopa/Levodopa/Entacapone	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Topiramate	Topiramate	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	13
Levetiracetam	Levetiracetam	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	28	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	suppressed
Nystatin	Nystatin	27	suppressed
Metformin Hcl Er	Metformin Hcl	26	suppressed
Levofloxacin	Levofloxacin	25	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	25	suppressed
Albuterol Sulfate	Albuterol Sulfate	24	suppressed
Glyburide	Glyburide	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	24	suppressed
Glipizide Er	Glipizide	23	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	22	22
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Clozapine	Clozapine	21	suppressed
Fenofibrate	Fenofibrate,micronized	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Meclizine Hcl	Meclizine Hcl	20	12
Methotrexate	Methotrexate Sodium	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Spiriva Handihaler	Tiotropium Bromide	19	suppressed
Valsartan	Valsartan	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Baclofen	Baclofen	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Mesalamine Dr	Mesalamine	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Sucralfate	Sucralfate	16	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Ranolazine Er	Ranolazine	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Primidone	Primidone	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Temazepam	Temazepam	14	suppressed
Folic Acid	Folic Acid	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Risperidone	Risperidone	13	suppressed
Tiadylt Er	Diltiazem Hcl	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Cabergoline	Cabergoline	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Sulfasalazine	Sulfasalazine	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Linzess	Linaclotide	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error